Cardinal Health Inc (CAH)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $65.61B
Last updated: Nov 17, 2026 at 4:33 PM ET
Cardinal Health Inc (CAH) Statistics
Cardinal Health (CAH) has a market cap of $65.61B and an enterprise value of $69.16B. Its trailing P/E of 23.3x is above its 10-year median of 13.2x. Its return on invested capital of 37.56% compares with a 9.62% median across 12 similar companies.
Total Valuation
Enterprise value is 5.41% above the market cap, as debt exceeds cash.
| Market Cap | $65.61B |
|---|---|
| Enterprise Value | $69.16B |
| Latest price (Nov 17, 2026) | $279.24 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Jan 4, 2027.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Next Ex-Dividend Date | Jan 4, 2027 |
| Next Payment Date | Jan 15, 2027 |
| Fiscal Year End | June |
Valuation Ratios
The price to sales ratio is 0.3x. Its year-end P/E ranged from 9.0x to 21.4x from 2016 to 2025.
| P/E Ratio | 23.3x |
|---|---|
| Forward P/E | 21.8x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.2x |
| P/FCF Ratio | 13.2x |
| P/OCF Ratio | 11.7x |
| PEG Ratio | 1.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 18.5x EBITDA and 13.9x free cash flow.
| EV / Earnings | 38.3x |
|---|---|
| EV / Sales | 0.3x |
| EV / EBITDA | 18.5x |
| EV / EBIT | 25.4x |
| EV / FCF | 13.9x |
Price Statistics
The stock is up 36.64% over 52 weeks and trades 13.73% above its 50-day average.
| Beta (1Y) | -0.01 |
|---|---|
| 52-Week Change | +36.64% |
| 1-Month Change | +10.52% |
| 3-Month Change | +19.17% |
| 6-Month Change | +39.98% |
| 5-Year Change | +423.91% |
| 10-Year Change | +264.65% |
| Total Return (1Y) | +37.64% |
| Total Return (3Y CAGR) | +40.81% |
| Total Return (5Y CAGR) | +44.11% |
| Return vs SPY (1Y) | +24.02% |
| Max Drawdown (1Y) | -20.57% |
| Max Drawdown (3Y) | -20.57% |
| Sharpe Ratio (1Y) | 1.19 |
| Correlation with SPY (1Y) | -0.01 |
| 50-Day Average | $245.53 |
| 200-Day Average | $225.17 |
| 52-Week Range | $179.64 to $286.29 |
| RSI (14 Days) | 71.8 |
| Average Volume (20 Days) | 1.69M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.88x current liabilities.
| Current Ratio | 0.88x |
|---|---|
| Quick Ratio | 0.49x |
| Debt / EBITDA | 2.39x |
| Debt / FCF | 1.80x |
| Interest Coverage | 7.99x |
Returns and Efficiency
Return on invested capital is 37.56% over the last 12 months, against a 5-year average of 25.23%.
| Return on Assets (ROA) | 3.03% |
|---|---|
| Return on Invested Capital (ROIC) | 37.56% |
| Return on Capital Employed (ROCE) | 20.62% |
| ROA (5Y Average) | 1.29% |
| ROIC (5Y Average) | 25.23% |
| Asset Turnover | 4.49x |
| Inventory Turnover | 13.88x |
| Receivables Turnover | 18.18x |
| Cash Conversion Cycle | -12 days |
Taxes
Income tax took 20.19% of pretax income over the last 12 months.
| Income Tax (TTM) | $457.00M |
|---|---|
| Effective Tax Rate | 20.19% |
Scores
CAH has an Altman Z-Score of 5.05, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.05 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $257.75B over the last 12 months is up 10.00% from the 12 months before.
| Revenue | $257.75B |
|---|---|
| Revenue Growth (YoY) | +10.00% |
| Gross Profit | $10.05B |
| Operating Income | $2.70B |
| Pretax Income | $2.26B |
| Net Income | $1.81B |
| EBITDA | $3.69B |
| EBIT | $2.73B |
| Reported EPS (TTM) | $11.97 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $5.26B |
|---|---|
| Total Debt | $8.81B |
| Net Debt | $3.55B |
| Net Debt Per Share | $15.31 |
| Working Capital | -$5.34B |
| Shareholder Equity | -$3.02B |
| Tangible Book Value | -$16.71B |
| Total Assets | $59.54B |
| Total Liabilities | $62.41B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $698.00M of capital spending, operating cash flow left $4.90B of free cash flow.
| Operating Cash Flow | $5.60B |
|---|---|
| Capital Expenditures | $698.00M |
| Free Cash Flow | $4.90B |
| FCF Per Share | $21.17 |
| Depreciation and Amortization | $970.00M |
| Dividends Paid | $499.00M |
| Share Repurchases | $1.48B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 1.05%, against a 5-year average of 0.53%.
| Gross Margin | 3.90% |
|---|---|
| Operating Margin | 1.05% |
| Pretax Margin | 0.88% |
| Net Margin | 0.70% |
| EBITDA Margin | 1.43% |
| EBIT Margin | 1.06% |
| FCF Margin | 1.90% |
| Gross Margin (5Y Average) | 3.54% |
| Operating Margin (5Y Average) | 0.53% |
| Net Margin (5Y Average) | 0.28% |
Growth
Revenue grew 7.44% a year over 3 years, and EPS 24.68% a year.
| Revenue Growth (3Y CAGR) | +7.44% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.37% |
| EPS Growth (3Y CAGR) | +24.68% |
| EPS Growth (5Y CAGR) | +15.20% |
| FCF Growth (3Y CAGR) | +24.18% |
| FCF Growth (5Y CAGR) | +17.40% |
| Operating Income Growth (3Y CAGR) | +51.46% |
Dividends and Yields
CAH pays out 8.51% of earnings as dividends.
| Dividend Per Share (Annual) | $2.06 |
|---|---|
| Dividend Yield | 0.74% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +0.91% |
| Dividend Growth (5Y CAGR) | +0.95% |
| Payout Ratio | 8.51% |
| FCF Payout Ratio | 10.18% |
| Earnings Yield | 4.29% |
| FCF Yield | 7.57% |
| Buyback Yield | 2.29% |
| Shareholder Yield | 3.06% |
Stock Splits
The last split was a 3-for-2 forward split on Apr 23, 2001.
| Last Split Date | Apr 23, 2001 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 10 similar companies, CAH has the 3rd highest P/E.
P/E RatioPeer median 15.9x
P/S RatioPeer median 0.5x
ROICPeer median 9.62%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.43%
Dividend YieldPeer median 0.48%
| P/E Ratio | 23.3x vs 15.9x median |
|---|---|
| P/S Ratio | 0.3x vs 0.5x median |
| ROIC | 37.56% vs 9.62% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.00% vs +7.43% median |
| Dividend Yield | 0.74% vs 0.48% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.39% and EPS growth at 13.01% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.39% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +13.01% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CAH
What is CAH's market cap?
Cardinal Health has a market cap of $65.61B. Its enterprise value, which adds debt and subtracts cash, is $69.16B.
What is CAH's P/E ratio?
Cardinal Health has a trailing P/E ratio of 23.3x and a forward P/E of 21.8x.
How many shares of CAH are outstanding?
Cardinal Health has 232.00M shares outstanding. The count is down 2.52% from a year earlier.
Does CAH pay a dividend?
Yes. Cardinal Health pays $2.06 a share a year, a dividend yield of 0.74%.
How much debt does CAH have?
Cardinal Health has $8.81B of total debt and $5.26B of cash and equivalents, a net debt position of $3.55B.
CAH pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts